Glimepiride

Specifications

Therapeutic Activity	Anti Diabetic
Standards	USP/ IP / BP/ EP
CAS. No.	93479-97-1

Glimepiride is an orally available medium-to-long acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.

Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce insulin.

MOLECULAR STRUCTURE:

Molecular formula : C₂₄H₃₄N₄O₅S
Molecular weight : 490.6
CAS Number : 93479-97-1
Application :. Anti-Diabetic
Specification : As perUSP/ BP/ EP/ IP
Chemical Name [IUPAC Name]: 1-[[4-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]phenyl] sulphony l] -3-trans-(4-methylcyclohexyl)urea.